Evaluation of rapid diagnostic tests and assessment of risk factors in drug-resistant pulmonary tuberculosis
Vimal Kumar, Pankaj Jorwal, Manish Soneja, Sanjeev Sinha, Neeraj Nischal, Prayas Sethi, Saikat Mondal, Zia Abdullah, et al. (9 authors)
Journal of Family Medicine and Primary Care · 2020-01
Abstract
BACKGROUND: Early diagnosis and treatment of drug-resistant tuberculosis (TB) is crucial to halt the spread of drug resistance in the community. AIM: The aim of the study was to compare rapid diagnostic tests (GeneXpert and line probe assay, LPA) with conventional liquid culture for the diagnosis of drug-resistant TB and to assess the risk factors for it. METHOD: value of < 0.05 was considered significant. RESULTS: value < 0.05). CONCLUSION: Both rapid diagnostic tests have very high sensitivity and specificity for detection of drug resistance in sputum smear positive with the advantage of short turn-around time. Defaulting to antitubercular therapy, contact with resistant TB, and disseminated disease are significant risk factors for drug resistance.
MeSH terms
- Medicine
- GeneXpert MTB/RIF
- Drug resistance
- Internal medicine
- Tuberculosis
- Sputum
- Drug
- Confidence interval
- Rifampicin
- Drug resistant tuberculosis
- Mycobacterium tuberculosis
- Gastroenterology